Freeze and fight: new combo tackles Hard-to-Treat melanoma

NCT ID NCT03949153

First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 26 times

Summary

This early-phase study tested a new approach for stage IIIB/C melanoma that has spread to lymph nodes. Doctors used a freezing technique (cryotherapy) to destroy accessible tumors, then injected the immunotherapy drug ipilimumab directly into the treated area, along with a flat dose of nivolumab given through the vein. The goal was to see if this combination is safe and feasible, and to get early clues about whether it can shrink both treated and untreated tumors. Nineteen adults with lymph node metastases took part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MELANOMA (SKIN) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Clinique Dermatologique/Radiologie Interventionnelle/Urologie/Gynécologie-CHU de Strasbourg/ICANS

    Strasbourg, 67091, France

Conditions

Explore the condition pages connected to this study.